GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $14.97 $17.43 Friday, 19th Apr 2024 CPRX stock ended at $15.13. This is 1.37% less than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 5.12% from a day low at $15.03 to a day high of $15.80.
90 days $13.12 $17.50
52 weeks $11.09 $17.77

Historical Catalyst Pharmaceuticals prices

Date Open High Low Close Volume
2021-06-02 $5.53 $5.59 $5.45 $5.56 901 987
2021-06-01 $5.53 $5.59 $5.46 $5.53 678 404
2021-05-28 $5.61 $5.66 $5.52 $5.53 790 936
2021-05-27 $5.60 $5.62 $5.46 $5.58 1 395 916
2021-05-26 $5.40 $5.64 $5.40 $5.59 915 232
2021-05-25 $5.68 $5.69 $5.38 $5.40 1 216 176
2021-05-24 $5.77 $5.83 $5.63 $5.69 917 412
2021-05-21 $5.65 $5.85 $5.61 $5.70 885 769
2021-05-20 $5.57 $5.71 $5.48 $5.61 982 382
2021-05-19 $5.60 $5.61 $5.47 $5.56 1 168 179
2021-05-18 $5.49 $5.68 $5.42 $5.63 1 056 510
2021-05-17 $5.54 $5.57 $5.42 $5.49 1 507 637
2021-05-14 $5.03 $5.54 $4.99 $5.51 2 481 124
2021-05-13 $4.90 $5.05 $4.82 $4.98 1 490 034
2021-05-12 $4.69 $5.05 $4.69 $4.86 2 208 371
2021-05-11 $4.55 $4.83 $4.43 $4.74 1 398 368
2021-05-10 $4.82 $4.95 $4.66 $4.82 2 145 933
2021-05-07 $4.61 $4.92 $4.61 $4.83 1 457 272
2021-05-06 $4.61 $4.69 $4.58 $4.67 1 002 447
2021-05-05 $4.63 $4.75 $4.58 $4.62 1 022 368
2021-05-04 $4.77 $4.79 $4.61 $4.64 1 627 410
2021-05-03 $4.57 $4.90 $4.57 $4.87 2 181 795
2021-04-30 $4.76 $4.81 $4.57 $4.58 1 037 174
2021-04-29 $4.74 $4.83 $4.70 $4.75 899 573
2021-04-28 $4.61 $4.76 $4.61 $4.72 741 407
Click to get the best stock tips daily for free!

About Catalyst Pharmaceuticals

Catalyst Pharmaceuticals Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company also develop... CPRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT